The University of Sydney, Sydney, New South Wales, Australia.
Res Social Adm Pharm. 2012 Sep-Oct;8(5):397-407. doi: 10.1016/j.sapharm.2011.10.003. Epub 2012 Jan 4.
Existing validated measures of pharmacist-physician collaboration focus on measuring attitudes toward collaboration and do not measure frequency of collaborative interactions.
To develop and validate an instrument to measure the frequency of collaboration between pharmacists and general practitioners (GPs) from the pharmacist's perspective.
An 11-item Pharmacist Frequency of Interprofessional Collaboration Instrument (FICI-P) was developed and administered to 586 pharmacists in 8 divisions of general practice in New South Wales, Australia. The initial items were informed by a review of the literature in addition to interviews of pharmacists and GPs. Items were subjected to principal component and Rasch analyses to determine each item's and the overall measure's psychometric properties and for any needed refinements.
Two hundred and twenty four (38%) of pharmacist surveys were completed and returned. Principal component analysis suggested removal of 1 item for a final 1-factor solution. The refined 10-item FICI-P demonstrated internal consistency reliability at Cronbach's alpha=0.90. After collapsing the original 5-point response scale to a 4-point response scale, the refined FICI-P demonstrated fit to the Rasch model. Criterion validity of the FICI-P was supported by the correlation of FICI-P scores with scores on a previously validated Physician-Pharmacist Collaboration Instrument. Validity was also supported by predicted differences in FICI-P scores between subgroups of respondents stratified on age, colocation with GPs, and interactions during the intern-training period.
The refined 10-item FICI-P was shown to have good internal consistency, criterion validity, and fit to the Rasch model. The creation of such a tool may allow for the measure of impact in the evaluation of interventions designed to improve interprofessional collaboration between GPs and pharmacists.
现有的药师-医师合作的验证性衡量标准侧重于衡量合作态度,而不衡量合作互动的频率。
从药师的角度开发和验证一种衡量药师与全科医生(GP)合作频率的工具。
在澳大利亚新南威尔士州的 8 个全科医学分部中,向 586 名药师发放了由 11 个项目组成的药师间专业合作频率量表(FICI-P)。最初的项目是通过文献回顾以及对药师和 GP 的访谈得出的。项目经过主成分和 Rasch 分析,以确定每个项目和整体衡量标准的心理测量特性和任何需要的改进。
224 名(38%)药师完成并交回了调查。主成分分析建议删除 1 项,以得出最终的 1 因素解决方案。经过精炼的 10 项 FICI-P 表现出 Cronbach's alpha=0.90 的内部一致性信度。在将原始的 5 点反应量表折叠为 4 点反应量表后,经过精炼的 FICI-P 符合 Rasch 模型。FICI-P 的标准有效性得到了与先前验证的医师-药师合作工具的分数相关的支持。有效性也得到了基于年龄、与 GP 的共置以及在实习培训期间的交互等因素对回答者分组的预测差异的支持。
经过精炼的 10 项 FICI-P 表现出良好的内部一致性、标准有效性和与 Rasch 模型的拟合度。这种工具的创建可能允许衡量旨在改善 GP 和药师之间的专业合作的干预措施的影响。